Acute toxicity and antihyperlipidemic activity of rhizome of Tectaria coadunata (Kukkutnakhi): A folklore herb
Journal name: AYU (Journal of Research in Ayurveda)
Original article title: Acute toxicity and antihyperlipidemic activity of rhizome of Tectaria coadunata (Kukkutnakhi): A folklore herb
AYU is an internationally recognized quarterly journal dedicated to advancing research in Ayurveda. The journal covers a wide range of topics, including clinical and pharmacological research in Ayurveda's eight branches, herbal remedies, phytochemistry, and ethnomedicine.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Hardik Mori
K. Nishteswar
B. R. Patel
Mukesh Nariya
AYU (Journal of Research in Ayurveda):
(An International Quarterly Journal of Research in Ayurveda)
Full text available for: Acute toxicity and antihyperlipidemic activity of rhizome of Tectaria coadunata (Kukkutnakhi): A folklore herb
Year: 2016 | Doi: 10.4103/ayu.AYU_109_14
Copyright (license): CC BY-NC-SA 4.0
Download the PDF file of the original publication
Summary of article contents:
Background: Tectaria coadunata (Wall. Ex Hook and Grev.) C. Chr (Kukkutnakhi) is a pteridophyte fern which is found in Western Ghats, Kerala Ghats, and Mahendragiri forest region. It is used by many Vaidyas in hyperlipidemic conditions and obesity.
Other Science Concepts:
Discover the significance of concepts within the article: �Acute toxicity and antihyperlipidemic activity of rhizome of Tectaria coadunata (Kukkutnakhi): A folklore herb�. Further sources in the context of Science might help you critically compare this page with similair documents:
Ayurvedic Materia Medica, Traditional use, Lipid profile, Histopathological study, Acute toxicity study, Pharmacognosy laboratory, Tribal medicine, Serum biochemical parameters, Serum urea, Cholesterol level, Normal control group, Acute oral toxicity, Hyperlipidemic conditions, Antihyperlipidemic activity, Cholesterol control group, Very-low-density lipoprotein cholesterol, Cholesterol administration, Preclinical research, Experimental animal, Wistar rat, Folklore claim.